- We expect sales growth of 15% YoY to INR7.88b; toothpaste volume growth is estimated at 8-9%.
- Convergence of urban and rural growth (rural was growing at higher rates earlier) indicates continued moderation in toothpaste volumes.
- During the quarter, Colgate launched its new offering in the gum-care segment - Colgate Pro Gum. Subsequently, GSK Consumer entered the specialty segment with its offering - Parodontax.
- We expect 180bp contraction in EBITDA margin at 22.4% on account of higher ad spends due to product launches, and sales promotion due to heightened competitive activity by other players.
- Higher tax rate at ~27% (up 240bp YoY) shall result in muted 5% increase in PAT to INR1.37b.
- The stock trades at 28.1x FY14E and 23.9x FY15E EPS. Neutral.